Highly Recommended S -Sitagliptin CAS 823817-55-6 White Powder for Diabetes Medication

Product Description:

Product Name: (S)-Sitagliptin CAS NO: 823817-55-6

Synonyms:

(S)-3-amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one;

Chemical & Physical Properties:

Appearance : White powder

Assay :≥97.0%

Density: 1.61g/cm3

Boiling Point:529.9℃at 760 mmHg

Sitagliptin is a new type of anti-type II diabetes drug approved by the FDA and the first dipeptidyl peptidase-IV inhibitor drug used to treat type II diabetes. Sitagliptin's mechanism of action is different from previous oral hypoglycemic drugs. It improves the ability of diabetic patients' own pancreatic islet β cells to produce insulin and increases the secretion of insulin when blood sugar rises, thereby controlling the blood glucose level of diabetic patients. Clinical studies have shown that sitagliptin is an orally effective drug with good market prospects. It has a significant hypoglycemic effect when used alone or in combination with metformin and pioglitazone, and is safe to take, well tolerated, and has fewer adverse reactions.

If you are interested in our products or have any questions, please feel free to contact us!

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.